Speaker Profile
PhD, Vice President, Clinical Pharmacology Sciences, Gilead
Biography
Dr. Sandhya Girish is the Vice President of Clinical Pharmacology Sciences at Gilead Sciences, Inc. Dr. Girish provides strategic and scientific leadership for clinical pharmacology, pharmacometrics and bioanalytical strategies for NMEs spanning both early and late stages of development. Her department is actively involved in a variety of pediatric and adult RD programs across virology, oncology, and inflammation therapeutics areas and is responsible for integrated clinical pharmacology, and MS strategies, including applying MIDD approaches where appropriate. Sandhya has organized technical sessions, workshops and roundtable discussions on therapeutic protein drug interactions, ADCsTDCs, Novel Combinations, Organ Impairment, FIH dosing etc. With support from her team Dr. Girish has successfully led and supported numerous submissions, including but not limited to Herceptin, Perjeta, Kadcyla, TECENTRIQ, POLIVY, Trodelvy, Sunlenca, etc. Sandhya is passionate about combining insights from clinical trials with data from virtual clinical trials, RWD, AIML to accelerate drug development.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Razelle Kurzrock, Medical College of Wisconsin
- PMWC 2024 Award Ceremony:
Luminary Honoree: Catriona Jamieson, UCSD Health
- Keynote: Targeting Cancer Stem Cells in Precision Oncology
- Catriona Jamieson, UCSD Health
- Revolutionizing Clinical Trials: Precision Oncology and Novel Trial Designs (PANEL)
Chair: Razelle Kurzrock, MCW
- Andrea Cercek, Memorial Sloan Kettering
- Apostolia Tsimberidou, MD Anderson
- Ben George, MCW
- Transcriptomics in Precision Oncology: Opportunities and Limitations (PANEL)
Chair: Razelle Kurzrock, MCW
- Andrea Califano, Columbia University
- Charles Perou, University of North Carolina
- Eytan Ruppin, NIH
- Bruce Quinn, Bruce Quinn Assoc LL
- David W. Craig, City of Hope Cancer Center - Legislation Mandating Insurance Coverage for Biomarker Testing
- Kathryn Phillips, UCSF
- Collaborative Frontiers: Transforming Cancer Care Access and Patient Outcomes (PANEL)
Chair: Maggie Rougier-Chapman, Labcorp
- Jennifer Rushton, Baptist Health System San Antonio, TX
- Rebecca Previs, Duke Cancer Institute
- Suzanne Garner, Outcomes4Me
- Taylor Jensen, Labcorp - Exploring the Clinical Utility of Dynamic ctDNA Monitoring
Chair: Lincoln Pasquina, Foundation Medicine
- Hatim Husain, UCSD - Antibody-Drug Conjugates (ADCs): Tracing the Evolution and Forecasting the Future (PANEL)
Chair: Adrian Lee, UPMC
- Sandhya Girish, Gilead
- Neelima Denduluri, Astra Zeneca
- Hope S. Rugo, UCSF - PMWC Showcase
- Michael Milburn, Genecentric Tx
- Robert Cook, Castle Bio
- Mark P. de Souza,SonALAsense, Inc.
- Amrie Grammer, Ampel Biosolutions - NCI Showcase
- Nick Reder, Alpenglow Bio
